Search - tctmd.com

Displaying 521 - 540 of 1502

Sort: Relevancy | Date

Presentation

Five-Year Clinical Outcome of the Nobori DES in the Treatment of Patients With CAD

Presenter: Bernard Chevalier

January 12, 2015

Presentation

The Incremental Risk of NoncardiacSurgery on Adverse Cardiac Events

Presenter: C.N. Holcomb

January 05, 2015

Presentation

CABG Surgery vs DES for Patients with Isolated Proximal LAD Disease

Presenter: Edward L. Hannan

December 22, 2014

Presentation

Beyond the Early Stages: Insights from the ASSURE Registry on Bioresorbable Vascular Scaffolds

Presenter: J. W?hrle

December 21, 2014

Presentation

Stent Coverage and Neointimal Proliferation in BMS Postdilated With a Paclitaxel-Eluting Balloon vs EES

Presenter: T.C. Poerner

December 14, 2014

Presentation

Clinical Presentation and Outcomes of Coronary In-Stent Restenosis Across 3 Stent Generations

Presenter: MA Magalhaes

December 11, 2014

Presentation

Hybrid Revascularization for Multivessel CAD

Presenter: M Gasior

November 25, 2014

Presentation AHA 2014

Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent

Presenter: Dean J. Kereiakes

November 16, 2014

Presentation AHA 2014

Long-term Outcome of Biodegradable Compared to Durable Polymer Drug-Eluting Stents and Bare Metal Stents – Main Results of a Prospective Randomized Trial

Presenter: C.Kaiser

November 16, 2014

Presentation

Long-term Outcome of SES and ZES Implantation in Patients With and Without Diabetes

Presenter: K.K.W. Olesen

November 13, 2014

Presentation

SECURITY: Second-Generation DES Implantation Followed by 6- vs 12-Month DAPT

Presenter: Antonio Colombo

November 10, 2014

Presentation

Impact of DES on the Comparative Effectiveness of CABG and PCI

Presenter: Mark A. Hlatky

November 03, 2014

Presentation

Bioresorbable Scaffold (BRS) Induces Neointimal Cap That Seals Plaque Without Compromising Lumen Size

Presenter: C.V. Bourantas

November 02, 2014

Presentation

Three-Year Clinical Outcome of Patients With Bifurcation Treatment With Second-Generation Resolute and Xience V Stents

Presenter: M.K. Lam

October 31, 2014

Presentation

New-Generation DES Reduce Stent Thrombosis and MI

Presenter: Luigi Vignali

October 28, 2014

Presentation Cardiovascular Interventions 2014

The Next Wave of Stent Design II: Bioresorbable Polymers

Presenter: Matthew J. Price

October 24, 2014

Presentation Cardiovascular Interventions 2014

How to Manage Post PCI Antiplatelet Therapy in the Patient on Oral Anticoagulation

Presenter: David P. Faxon

October 23, 2014

Presentation

TCT 2014 Top Late Breaking Trials: Coronary Studies

Presenter: Gregg W. Stone

October 21, 2014

Presentation

DEBs for Femoropopliteal Lesions Show Better Performance in De Novo Stenosis Than Restenosis

Presenter: Monika Herten

October 16, 2014

Presentation

Influence of Second- and Third-Degree Heart Block on 30-Day Outcomes After AMI in the DES Era

Presenter: H.L. Kim

October 09, 2014

Advertisement

Five-Year Clinical Outcome of the Nobori DES in the Treatment of Patients With CAD

The Incremental Risk of NoncardiacSurgery on Adverse Cardiac Events

CABG Surgery vs DES for Patients with Isolated Proximal LAD Disease

Beyond the Early Stages: Insights from the ASSURE Registry on Bioresorbable Vascular Scaffolds

Stent Coverage and Neointimal Proliferation in BMS Postdilated With a Paclitaxel-Eluting Balloon vs EES

Clinical Presentation and Outcomes of Coronary In-Stent Restenosis Across 3 Stent Generations

Hybrid Revascularization for Multivessel CAD

Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent

Long-term Outcome of Biodegradable Compared to Durable Polymer Drug-Eluting Stents and Bare Metal Stents – Main Results of a Prospective Randomized Trial

Long-term Outcome of SES and ZES Implantation in Patients With and Without Diabetes

SECURITY: Second-Generation DES Implantation Followed by 6- vs 12-Month DAPT

Impact of DES on the Comparative Effectiveness of CABG and PCI

Bioresorbable Scaffold (BRS) Induces Neointimal Cap That Seals Plaque Without Compromising Lumen Size

Three-Year Clinical Outcome of Patients With Bifurcation Treatment With Second-Generation Resolute and Xience V Stents

New-Generation DES Reduce Stent Thrombosis and MI

The Next Wave of Stent Design II: Bioresorbable Polymers

How to Manage Post PCI Antiplatelet Therapy in the Patient on Oral Anticoagulation

TCT 2014 Top Late Breaking Trials: Coronary Studies

DEBs for Femoropopliteal Lesions Show Better Performance in De Novo Stenosis Than Restenosis

Influence of Second- and Third-Degree Heart Block on 30-Day Outcomes After AMI in the DES Era

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content